NCT01150565 - Safety Study of LiRIS in Interstitial Cystitis (IC) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Interstitial Cystitis

Interventions

DRUG

LiRIS low dose and LiRIS high dose

Drug delivery system containing lidocaine; LiRIS (low or high dose) is inserted into bladder via cystoscopy on Day 1 and removed via cystoscopy on Day 14. Designed to release lidocaine over a 14 day period.

Trial Locations (3)

V8V 3N1

Dr. Steinhoff Clinical Research, Victoria

B3H 3A7

Queen Elizabeth II Health Sciences Centre, Halifax Infirmary, Halifax

K7L 3J7

Centre for Applied Urological Research, Kingston